Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group.
Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, Tesoro T, Scott AM, von Gizycki R, Nguyen F, Hareendran A, Patrick DL, Perfetto EM. Harrington RL, et al. Among authors: camp r. Value Health. 2020 Jun;23(6):677-688. doi: 10.1016/j.jval.2020.01.019. Epub 2020 May 23. Value Health. 2020. PMID: 32540224 Free article.
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations.
Roennow A, Sauvé M, Welling J, Riggs RJ, Kennedy AT, Galetti I, Brown E, Leite C, Gonzalez A, Portales Guiraud AP, Houÿez F, Camp R, Gilbert A, Gahlemann M, Moros L, Luna Flores JL, Schmidt F, Sauter W, Finnern H. Roennow A, et al. Among authors: camp r. BMJ Open. 2020 Dec 16;10(12):e039473. doi: 10.1136/bmjopen-2020-039473. BMJ Open. 2020. PMID: 33328257 Free PMC article.
Monitoring and Evaluation of Patient Engagement in Health Product Research and Development: Co-Creating a Framework for Community Advisory Boards.
Fruytier SE, Vat LE, Camp R, Houÿez F, De Keyser H, Dunne D, Marchi D, McKeaveney L, Pitt RH, Pittens CACM, Vaughn MF, Zhuravleva E, Schuitmaker-Warnaar TJ. Fruytier SE, et al. Among authors: camp r. J Patient Cent Res Rev. 2022 Jan 17;9(1):46-57. doi: 10.17294/2330-0698.1859. eCollection 2022 Winter. J Patient Cent Res Rev. 2022. PMID: 35111882 Free PMC article.
Policy recommendations for rare disease centres of expertise.
Syed AM, Camp R, Mischorr-Boch C, Houÿez F, Aro AR. Syed AM, et al. Among authors: camp r. Eval Program Plann. 2015 Oct;52:78-84. doi: 10.1016/j.evalprogplan.2015.03.006. Epub 2015 Apr 16. Eval Program Plann. 2015. PMID: 25935363
Co-creation of practical "how-to guides" for patient engagement in key phases of medicines development-from theory to implementation.
Feldman D, Kruger P, Delbecque L, Duenas A, Bernard-Poenaru O, Wollenschneider S, Hicks N, Reed JA, Sargeant I, Pakarinen C, Hamoir AM; Patient Focused Medicines Development Working Groups 1; Patient Focused Medicines Development Working Groups 2A; Patient Focused Medicines Development Working Groups 2B. Feldman D, et al. Res Involv Engagem. 2021 Aug 23;7(1):57. doi: 10.1186/s40900-021-00294-x. Res Involv Engagem. 2021. PMID: 34425911 Free PMC article.
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.
Moeder CB, Giltnane JM, Harigopal M, Molinaro A, Robinson A, Gelmon K, Huntsman D, Camp RL, Rimm DL; American Society of Clinical Oncology; College of American Pathologists. Moeder CB, et al. J Clin Oncol. 2007 Dec 1;25(34):5418-25. doi: 10.1200/JCO.2007.12.8033. J Clin Oncol. 2007. PMID: 18048824
325 results